Literature DB >> 2015714

Enhanced antiproliferative activity by metastatic RAW117 lymphoma cells.

S S Joshi1, S J O'Connor, D D Weisenburger, J G Sharp, H M Gharpure, K W Brunson.   

Abstract

The highly malignant/metastatic murine large cell lymphoma cell line RAW117-H10 forms 100-200 times more liver metastatic tumors than its parental counterpart cell line RAW117-P. RAW117-H10 cells, but not the less malignant/metastatic parental cells, significantly inhibited the mitogen-induced proliferation of normal syngeneic Balb/c and allogeneic ICRC mouse spleen cells. Such an inhibition also occurred when mitomycin-C treated metastatic lymphoma cells were added 24 h after initiation of culture, indicating that no competition with mitogen binding sites on the lymphocytes was necessary for inhibition of proliferation. 'Antiproliferative' cell surface molecules were extracted non-cytolytically from the RAW117-H10 cells using butanol. The butanol extracts from the metastatic RAW117-H10 cells also inhibited the mitogen-induced proliferation and natural killer (NK) cell-mediated cytotoxicity of normal spleen cells. Our results indicate that these 'antiproliferative' cell surface molecules of metastatic murine RAW117-H10 lymphoma cells may have important role(s) in tumor-mediated host immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015714     DOI: 10.1007/bf01831707

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  27 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  1-Butanol extraction and subsequent reconstitution of membrane components which mediate metastatic phenotype.

Authors:  S J LeGrue
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

3.  Similarity between p15E of murine and feline leukaemia viruses and p21 of HTLV.

Authors:  G J Cianciolo; R J Kipnis; R Snyderman
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

4.  Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus.

Authors:  M L Poss; J I Mullins; E A Hoover
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

5.  Characterization of metastasis-associated antigens on RAW117 lymphosarcoma cell lines.

Authors:  S S Joshi; J G Sharp; H M Gharpure; K W Brunson
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

Review 6.  Noncytolytic extraction of cell surface antigens using butanol.

Authors:  S J LeGrue
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

7.  In vivo and in vitro properties of malignant variants of RAW117 metastatic murine lymphoma/lymphosarcoma.

Authors:  C L Reading; P M Kraemer; K M Miner; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1983 Apr-Jun       Impact factor: 5.150

8.  Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies.

Authors:  A J Cochran; E Pihl; D R Wen; D S Hoon; E L Korn
Journal:  J Natl Cancer Inst       Date:  1987-03       Impact factor: 13.506

9.  Differential growth characteristics of low and high metastatic variant RAW117 murine lymphosarcoma cells.

Authors:  S S Joshi; J G Sharp; K W Brunson
Journal:  Oncology       Date:  1987       Impact factor: 2.935

10.  Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70.

Authors:  C L Reading; K W Brunson; M Torrianni; G L Nicolson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  2 in total

1.  Interleukin-2 therapy of lymphoma-bearing immunosuppressed mice.

Authors:  S S Joshi; L J Messbarger; W Hao
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

2.  Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  J Cancer       Date:  2010-11-29       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.